Original Research
Accepted on 19 Dec 2024
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system
in Drugs Outcomes Research and Policies
Original Research
Accepted on 19 Dec 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 19 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 19 Dec 2024
in Land, Livelihoods and Food Security
Case Report
Accepted on 19 Dec 2024
in Neuroimaging
Original Research
Accepted on 19 Dec 2024
in Antimicrobials, Resistance and Chemotherapy
Review
Accepted on 19 Dec 2024
in Nanobiotechnology
Review
Accepted on 19 Dec 2024
in Bacteria and Host
Original Research
Accepted on 19 Dec 2024
in Drugs Outcomes Research and Policies
Review
Accepted on 19 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 19 Dec 2024
in Sustainable Energy Systems
Original Research
Accepted on 19 Dec 2024
in Biomechanics
Original Research
Accepted on 19 Dec 2024
in Environmental Analysis
Original Research
Accepted on 19 Dec 2024
in Health Psychology
Clinical Trial
Accepted on 19 Dec 2024
in Neuroimaging
Review
Accepted on 19 Dec 2024
in Neuroimaging
Review
Accepted on 19 Dec 2024
in Molecular Signalling and Pathways